Int. J. Mol. Sci. 2010, 11(12), 5323-5338; doi:10.3390/ijms11125323
Article

Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle

1 Faculty of Medical Technology, Mahidol University Main Campus, 999 Puttamonthon 4 street, Salaya, Nakornpathom 73170, Thailand 2 Faculty of Pharmacy, Mahidol University, Bangkok, Thailand 3 Faculty of Science, Ramkhamhaeng University, Bangkok, Thailand 4 Institute of Molecular Biosciences, Mahidol University, Bangkok, Thailand
* Author to whom correspondence should be addressed.
Received: 19 November 2010; in revised form: 20 December 2010 / Accepted: 21 December 2010 / Published: 22 December 2010
(This article belongs to the Section Biochemistry, Molecular Biology and Biophysics)
PDF Full-text Download PDF Full-Text [648 KB, uploaded 22 December 2010 11:41 CET]
Abstract: Naturally occurring cucurbitacins have been shown to have anticancer, antimicrobial and anti-inflammatory activities. In this study, we determined the effects of cucurbitacin B extracted from the Thai herb Trichosanthes cucumerina L. on telomerase regulation in three human breast cancer cell lines (T47D, SKBR-3, and MCF-7) and a mammary epithelium cell line (HBL-100). Cell viability after treatment with cucurbitacin B, which is an active ingredient of this herb, was assessed. Telomeric Repeat Amplification Protocol (TRAP) assays and RT-PCR (qualitative and realtime) were performed to investigate activity of telomerase as well as expression of human telomerase reverse transcriptase (hTERT) and c-Myc. The c-Myc protein level was also determined in SKBR-3 and HBL-100 cells. Our results show that the cucurbitacin B inhibits growth and telomerase activity in the three breast cancer cell lines and exerts an obvious inhibitory effect in the estrogen receptor (ER)-negative breast cancer SKBR-3 cells. The expression of hTERT and c-Myc were also inhibited by cucurbitacin B, In addition, a clear reduction of c-Myc protein was observed after treatment in SKBR-3 cells even with a concentration of cucurbitacin B that was ten-times lower compared to the concentration used for HBL-100. Our findings imply that cucurbitacin B exerts an anticancer effect by inhibiting telomerase via down regulating both the hTERT and c-Myc expression in breast cancer cells.
Keywords: cucurbitacin B; telomerase; hTERT; c-Myc; breast cancer; estrogen receptor

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Duangmano, S.; Dakeng, S.; Jiratchariyakul, W.; Suksamrarn, A.; Smith, D.R.; Patmasiriwat, P. Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle. Int. J. Mol. Sci. 2010, 11, 5323-5338.

AMA Style

Duangmano S, Dakeng S, Jiratchariyakul W, Suksamrarn A, Smith DR, Patmasiriwat P. Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle. International Journal of Molecular Sciences. 2010; 11(12):5323-5338.

Chicago/Turabian Style

Duangmano, Suwit; Dakeng, Sumana; Jiratchariyakul, Weena; Suksamrarn, Apichart; Smith, Duncan R.; Patmasiriwat, Pimpicha. 2010. "Antiproliferative Effects of Cucurbitacin B in Breast Cancer Cells: Down-Regulation of the c-Myc/hTERT/Telomerase Pathway and Obstruction of the Cell Cycle." Int. J. Mol. Sci. 11, no. 12: 5323-5338.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert